Clinical review of chondroitin sulfate in osteoarthritis.

[1]  S. Berney Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip , 2008 .

[2]  E. D. de Bruin,et al.  Chondroitin sulfate as a structure-modifying agent. , 2006, Advances in pharmacology.

[3]  E. D. de Bruin,et al.  Treatment of knee osteoarthritis with oral chondroitin sulfate. , 2006, Advances in pharmacology.

[4]  N. Volpi Chondroitin sulfate : structure, role and pharmacological activity , 2006 .

[5]  E. Vignon,et al.  Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. , 2005, Arthritis and rheumatism.

[6]  E. Vignon,et al.  Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. , 2004, Osteoarthritis and cartilage.

[7]  G. Verbruggen,et al.  Systems to Assess the Progression of Finger Joint Osteoarthritis and the Effects of Disease Modifying Osteoarthritis Drugs , 2002, Clinical Rheumatology.

[8]  B. Mazières,et al.  Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. , 2001, The Journal of rheumatology.

[9]  D. Felson,et al.  Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. , 2000, JAMA.

[10]  B. Leeb,et al.  A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. , 2000, The Journal of rheumatology.

[11]  H. Vet,et al.  The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. , 1998, Journal of clinical epidemiology.

[12]  T. Conrozier [Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6)]. , 1998, Presse medicale.

[13]  J. Dehais,et al.  Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. , 1998, Osteoarthritis and cartilage.

[14]  E. Thonar,et al.  Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. , 1998, Osteoarthritis and cartilage.

[15]  G. Verbruggen,et al.  Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. , 1998, Osteoarthritis and cartilage.

[16]  L. Bucsi,et al.  Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. , 1998, Osteoarthritis and cartilage.

[17]  G. Verbruggen,et al.  Numerical scoring systems for the anatomic evolution of osteoarthritis of the finger joints. , 1996, Arthritis and rheumatism.

[18]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.